X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (378) 378
Publication (39) 39
Web Resource (5) 5
Book / eBook (4) 4
Book Chapter (3) 3
Patent (3) 3
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (200) 200
male (138) 138
oncology (122) 122
cancer (95) 95
index medicus (87) 87
aged (84) 84
middle aged (84) 84
chemotherapy (76) 76
female (73) 73
adult (70) 70
antineoplastic combined chemotherapy protocols - therapeutic use (62) 62
treatment outcome (51) 51
prognosis (50) 50
urology & nephrology (46) 46
cisplatin (38) 38
aged, 80 and over (36) 36
survival (36) 36
care and treatment (35) 35
antineoplastic combined chemotherapy protocols - adverse effects (33) 33
antineoplastic agents - therapeutic use (32) 32
life sciences (32) 32
metastasis (32) 32
prostate cancer (32) 32
cisplatin - administration & dosage (30) 30
urology (30) 30
neoplasm staging (27) 27
docetaxel (26) 26
neoplasm metastasis (26) 26
deoxycytidine - analogs & derivatives (25) 25
urinary bladder neoplasms - drug therapy (23) 23
prostatic neoplasms - drug therapy (22) 22
retrospective studies (22) 22
carcinoma (21) 21
hematology, oncology and palliative medicine (21) 21
survival rate (21) 21
adolescent (20) 20
deoxycytidine - administration & dosage (20) 20
surgery (20) 20
therapy (20) 20
prostatic neoplasms - pathology (19) 19
disease-free survival (18) 18
gemcitabine (18) 18
prospective studies (18) 18
testicular neoplasms - drug therapy (17) 17
time factors (17) 17
trial (17) 17
vinblastine - administration & dosage (17) 17
analysis (16) 16
carcinoma, renal cell - drug therapy (16) 16
kidney neoplasms - drug therapy (16) 16
urinary bladder neoplasms - pathology (16) 16
france (15) 15
survival analysis (15) 15
vinblastine (15) 15
antineoplastic agents (14) 14
antineoplastic combined chemotherapy protocols - administration & dosage (14) 14
doxorubicin (14) 14
drug administration schedule (14) 14
germinoma - drug therapy (14) 14
radiotherapy (14) 14
research (14) 14
testicular cancer (14) 14
testicular neoplasms - pathology (14) 14
tumors (14) 14
bladder cancer (13) 13
carcinoma, transitional cell - drug therapy (13) 13
combined modality therapy (13) 13
etoposide - administration & dosage (13) 13
follow-up studies (13) 13
human health and pathology (13) 13
kidney neoplasms - pathology (13) 13
prognostic factors (13) 13
antimitotic agents (12) 12
carcinoma, renal cell (12) 12
cisplatin - adverse effects (12) 12
clinical trials (12) 12
combination (12) 12
etoposide (12) 12
immunotherapy (12) 12
kidney neoplasms (12) 12
methotrexate (12) 12
risk factors (12) 12
sunitinib (12) 12
urology and nephrology (12) 12
carboplatin (11) 11
cisplatin - therapeutic use (11) 11
combination chemotherapy (11) 11
diagnosis (11) 11
disease progression (11) 11
health aspects (11) 11
mitoxantrone (11) 11
paclitaxel (11) 11
phase-ii trial (11) 11
renal cell carcinoma (11) 11
taxoids - administration & dosage (11) 11
testicular neoplasms - therapy (11) 11
[ sdv.can ] life sciences [q-bio]/cancer (10) 10
adenocarcinoma (10) 10
biomarkers, tumor - blood (10) 10
bleomycin (10) 10
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 7, pp. 787 - 794
Journal Article
European Journal of Cancer, ISSN 0959-8049, 07/2018, Volume 97, p. 30
During the 2000s, the development of taxane chemotherapies helped improve care and outcomes of patients with metastatic, castrate-resistant prostate cancer... 
Cell culture | Prostate-specific antigen | Taxane | Tumor cell lines | Survival | Metastases | Chemotherapy | Cell lines | Drug therapy | Mitoxantrone | Prostate cancer | Prostate | Cancer | Tumors
Journal Article
European Journal of Cancer, ISSN 0959-8049, 07/2018, Volume 97, pp. 30 - 32
Journal Article
Cancer Research, ISSN 0008-5472, 11/2010, Volume 70, Issue 22, pp. 9253 - 9264
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2009, Volume 4, Issue 10, p. e7542
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2017, Volume 376, Issue 11, pp. 1015 - 1026
Journal Article
Journal Article
European Urology, ISSN 0302-2838, 2015, Volume 70, Issue 2, pp. 256 - 262
Journal Article
La Revue du praticien, ISSN 0035-2640, 12/2014, Volume 64, Issue 10, p. 1399
Journal Article
Seminars in Oncology, ISSN 0093-7754, 02/2009, Volume 36, Issue 1, pp. 60 - 64
In patients with unknown primary cancer, the diagnostic uncertainty as to the nature of the primary cancer also affects the formulation of a prognosis. Only in... 
POORLY DIFFERENTIATED CARCINOMA | SURVIVAL | CISPLATIN | ONCOLOGY | PRIMARY SITE | PREDICT | ADENOCARCINOMA | MODEL | COMBINATION | CONSECUTIVE PATIENTS | Neoplasms, Unknown Primary - diagnosis | Clinical Trials as Topic | Prognosis | Biomarkers, Tumor - analysis | Humans | Neoplasms, Unknown Primary - therapy
Journal Article
La Revue du praticien, ISSN 0035-2640, 01/2018, Volume 68, Issue 1, p. 52
Medical treatment of metastatic kidney cancer: targeting the tumor micro-environment. Metastatic kidney cancer has a poor prognosis. Progress has been made in... 
Vascular Endothelial Growth Factor A | Humans | Immunotherapy | Nivolumab | Tumor Microenvironment | Kidney Neoplasms - pathology | Antibodies, Monoclonal | Kidney Neoplasms - therapy
Journal Article
Journal Article
International Journal of Urology, ISSN 0919-8172, 05/2015, Volume 22, Issue 5, pp. 495 - 495
Journal Article
2008, Collection Oncologie pratique, ISBN 9782287716508
Web Resource
2008, Collection Oncologie pratique, ISBN 9782287716508
Web Resource
2008, Collection Oncologie pratique, ISBN 9782287716508
Web Resource
European Journal of Cancer, ISSN 0959-8049, 2014, Volume 51, Issue 1, pp. 45 - 54
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.